Albert Labs a company accelerating access to psychedelic-based medicines for patients with urgent and unmet is expected to commence trading on the CSE under the ticker “ABRT” early in the new year. VANCOUVER, BC, Nov. 29, 2021 /CNW/ – Albert Labs (or the “Company”), today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange…


Previous articlePsychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US Patent; Leave Toads Alone?
Next articleRed Light Holland Reports Second Quarter 2021 Results